ID: ALA3597632

Max Phase: Preclinical

Molecular Formula: C35H32F5NO5

Molecular Weight: 641.63

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1c(CCCC(=O)O)c2c(F)ccc(C#Cc3ccc(OCCCCc4c(F)cc(F)c(F)c4F)cc3)c2n1CCCC(=O)O

Standard InChI:  InChI=1S/C35H32F5NO5/c1-21-25(7-4-8-30(42)43)32-27(36)17-14-23(35(32)41(21)18-5-9-31(44)45)13-10-22-11-15-24(16-12-22)46-19-3-2-6-26-28(37)20-29(38)34(40)33(26)39/h11-12,14-17,20H,2-9,18-19H2,1H3,(H,42,43)(H,44,45)

Standard InChI Key:  HOXJOAWSVADHMC-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 641.63

Molecular Weight (Monoisotopic): 641.2201

AlogP: 7.72

#Rotatable Bonds: 14

Polar Surface Area: 88.76

Molecular Species: ACID

HBA: 4

HBD: 2

#RO5 Violations: 2

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 3.95

CX Basic pKa:

CX LogP: 8.60

CX LogD: 2.62

Aromatic Rings: 4

Heavy Atoms: 46

QED Weighted: 0.05

Np Likeness Score: -0.77

References

1. Itadani S, Yashiro K, Aratani Y, Sekiguchi T, Kinoshita A, Moriguchi H, Ohta N, Takahashi S, Ishida A, Tajima Y, Hisaichi K, Ima M, Ueda J, Egashira H, Sekioka T, Kadode M, Yonetomi Y, Nakao T, Inoue A, Nomura H, Kitamine T, Fujita M, Nabe T, Yamaura Y, Matsumura N, Imagawa A, Nakayama Y, Takeuchi J, Ohmoto K..  (2015)  Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.,  58  (15): [PMID:26200813] [10.1021/acs.jmedchem.5b00741]

Source

Source(1):

• Scientific Literature